Cancer Cell
Volume 9, Issue 1, January 2006, Pages 23-32
Journal home page for Cancer Cell

Article
Requirement for CDK4 kinase function in breast cancer

https://doi.org/10.1016/j.ccr.2005.12.012Get rights and content
Under an Elsevier user license
open archive

Summary

Cyclin D1 is overexpressed in the majority of human breast cancers. We previously found that mice lacking cyclin D1 are resistant to mammary carcinomas triggered by the ErbB-2 oncogene. In this study, we investigated which function of cyclin D1 is required for ErbB-2-driven mammary oncogenesis. We report that the ability of cyclin D1 to activate cyclin-dependent kinase CDK4 underlies the critical role for cyclin D1 in breast cancer formation. We also found that the continued presence of CDK4-associated kinase activity is required to maintain breast tumorigenesis. We analyzed primary human breast cancers and found high cyclin D1 levels in a subset (∼25%) of ErbB-2-overexpressing tumors. We propose that this subset of breast cancer patients might benefit from inhibiting CDK4 kinase.

CELLCYCLE

Cited by (0)

6

Present address: Novartis Institutes for Biomedical Research, Cambridge, Massachusetts 02139